Average Co-Inventor Count = 6.0

ph-index = 5

Forward Citations = 88(Granted Patents)

Company Filing History:

14 out of 3,435

National Institutes of Health, a Component of the US Dept. of Health & Human Services

patents

6 out of 1,215

The United States of America As Represented by the Department of Health

patents

3 out of 2,202

The United States of America As Represented by the Secretary of

patents

4. 2 out of 16,070

USA As Represented by Secretary of the Navy

patents

5. 2 out of 2,340

University of Illinois

patents

6. 1 out of 470

Brigham Young University

patents

7. 1 out of 972

Arizona Board of Regents on Behalf of the University of Arizona

patents

8. 1 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 1995-2021

Loading Chart...

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11034736 - Anti-viral cnidarins (2021-06-15),

2. 10849912 - Method of sensitizing cancer cells to the cytotoxic effects of apoptosis inducing ligands in cancer treatment (2020-12-01),

3. 10246463 - Hypoxia-inducible factor 1 (HIF-1) inhibitors (2019-04-02),

4. 9937217 - Method of inhibiting ABCG2 and related treatments (2018-04-10),

5. 9314448 - Method of inhibiting ABCG2 and other treatment methods (2016-04-19),

6. 9114102 - Method of inhibiting ABCG2 and related treatments (2015-08-25),

7. 8729053 - Nuclear factor kappa B pathway inhibitor composition and use of same (2014-05-20),

8. 8481255 - Scytovirin domain 1 related polypeptides (2013-07-09),

9. 8470888 - Botryllamides and method of inhibiting PGP in a mammal afflicted with cancer (2013-06-25),

10. 8088729 - Anti-viral griffithsin compounds, compositions and methods of use (2012-01-03),

11. 8067530 - Scytovirin domain 1 related polypeptides (2011-11-29),

12. 6987096 - Antiviral proteins and peptides, DNA coding sequences therefor, and uses thereof (2006-01-17),

13. 6774141 - Calanolide and related antiviral compounds, compositions, and uses thereof (2004-08-10),

14. 6673830 - Calanolide and related antiviral compounds, compositions, and uses thereof (2004-01-06),

15. 6245737 - Conjugates of antiviral proteins or peptides and virus or viral envelope glycoproteins (2001-06-12),

Title: The Innovative Mind of James Brislin McMahon

Introduction

James Brislin McMahon, based in Frederick, MD, is a prolific inventor with an impressive portfolio of 26 patents. His work primarily focuses on advancements in anti-viral therapies and cancer treatment methodologies, showcasing his commitment to enhancing human health through innovative science.

Latest Patents

Among his latest patents, McMahon has developed groundbreaking technologies. One notable patent involves "Anti-viral cnidarins," an isolated and purified nucleic acid molecule that encodes a polypeptide with significant anti-viral activity. This patent encompasses various components, including a vector comprising the nucleic acid molecule, methods for producing the antiviral polypeptide, and compositions that incorporate the polypeptide or its conjugates. Additionally, McMahon has addressed cancer treatment through another significant patent, which details a method of sensitizing cancer cells to apoptosis-inducing ligands. This innovative method enhances the response of cancer cells to treatment, providing crucial insights into therapeutic strategies in oncology.

Career Highlights

James Brislin McMahon has significantly impacted the healthcare sector through his research and inventions. He has worked with esteemed organizations, including the United States Department of Health and Human Services, focusing on developing innovative health solutions. His career is a testament to the influence that well-structured research and patenting can have in addressing critical health challenges.

Collaborations

Throughout his career, McMahon has collaborated with notable professionals, including Kirk R. Gustafson and Michael R. Boyd. These partnerships have allowed for a rich exchange of ideas and expertise, further propelling innovative solutions in health sciences.

Conclusion

James Brislin McMahon stands out as a leading inventor with a keen focus on developing groundbreaking solutions in healthcare. With numerous patents to his name, his work reflects a dedication to improving therapeutic strategies for viral infections and cancer, marking him as a key contributor to advancements in health innovation.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.